2014 Annual Meeting | Contemporary Clinical Issues Plenary Session

Date Wednesday 04/30/14

Time 09:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Plenary Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, General Neurology, Movement Disorders, Sleep

CME Available No CME available

Event Timeline
09:00 AM - 09:05 AM		Introduction
09:05 AM - 09:20 AM		Comparison of Thrombolytic Treatment for Acute Ischemic Stroke Pre- and Post-Telemedicine Implementation in the Spoke Hospital Setting
09:20 AM - 09:35 AM		Abstract Discussion Lee H. Schwamm, MD, FAAN
09:35 AM - 09:50 AM		Epigenetic Therapy for Friedreich’s Ataxia: A Phase I Clinical Trial David R. Jacoby, MD, PhD
09:50 AM - 10:05 AM		Abstract Discussion Tetsuo Ashizawa, MD, FAAN
10:05 AM - 10:20 AM		Clinical Profile of the Orexin Receptor Antagonist Suvorexant for the Treatment of Insomnia in Phase-3 Clinical Trials William J. Herring, MD, PhD
10:20 AM - 10:35 AM		Abstract Discussion Phyllis C. Zee, MD, PhD
10:35 AM - 10:55 AM		Moving Toward Precision Medicine in the Epilepsies David B. Goldstein, PhD
10:55 AM - 11:15 AM		Functional (Psychogenic) Disorders in Neurology Jon Stone, PhD, MB, ChB, FRCP
11:15 AM - 11:35 AM		Parkinson’s Disease Progression Marker Initiative Kenneth L. Marek, MD

Faculty Disclosures
Phyllis C. Zee, MD, PhD	Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
David R. Jacoby, MD, PhD	No disclosure on file
William J. Herring, MD, PhD	No disclosure on file
	No disclosure on file
Tetsuo Ashizawa, MD, FAAN	An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Lee H. Schwamm, MD, FAAN	Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime Education. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
Kenneth L. Marek, MD	Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Jon Stone, PhD, MB, ChB, FRCP	Mr. Stone has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple UK legal firms. The institution of Mr. Stone has received research support from Scottish Government. Mr. Stone has received publishing royalties from a publication relating to health care.
David B. Goldstein, PhD	No disclosure on file